$14.57 -0.32 (-2.15%)
12/3/2009 4:02 PM

Emergent BioSolutions, Inc. (EBS)

CAPS Rating: 5 out of 5

A biopharmaceutical company focused on the development, manufacture and commercialization of immunobiotics. The Company operates in two business segments: biodefense and commercial.

Recs

1
Member Avatar sprucemoose2 (83.40) Submitted: 1/5/2009 2:27:31 PM : Outperform Start Price: $26.07 EBS Score: -65.14

has a constant revenue stream from the good ole US of A and sticks to its 50 day MA very well

Report this Post 0 Comments

Featured Broker Partners